In order to improve the early diagnosis rate and clinical efficacy of pancreatic cancer, some scholars have discovered and verified some biomarkers of the pancreatic cancer in recent years, such as S100 Calcium Binding Protein A6 (S100A6) [24] and Glypican 2 (GPC2) [25]. This evidence concerns the gene S100A6 and familial pancreatic carcinoma.